09:57 AM EST - QLT Inc. : reported financial results for the second quarter ended June 30, 2012. Unless specified otherwise, all amounts are in U.S. dollars and in accordance with U.S. Generally Accepted Accounting Principles (GAAP). For the second quarter, total revenue of $8.0 million was down $4.7 million or 37.0% from the prior year primarily due to lower U.S. Visudyne sales and because the prior year included $2.0 million of Net Product Revenue related to a shipment of Visudyne to Novartis, while the second quarter of 2012 included none. QLT Inc.
shares T.QLT are trading down $0.08 at $8.37.
